TruAlt Bioenergy IPO 2025 GMP, Subscription Live & Apply or Avoid

The IPO market in India continues to heat up, and one of the biggest names to hit Dalal Street this week is TruAlt Bioenergy IPO 2025. With a strong presence in ethanol, bio-fuels, and compressed biogas (CBG), the company is expected to benefit from India’s renewable energy push. Investors are closely tracking TruAlt Bioenergy IPO GMP today, subscription levels, and expert reviews to decide whether to apply or avoid.

In this detailed article, we bring you live updates on GMP, subscription trends, issue details, financial performance, strengths and risks. We also share our expert view on whether this IPO could deliver strong listing gains or should be approached with caution.

TruAlt Bioenergy IPO – Key Details at a Glance

The company has positioned itself as one of the fastest-growing players in the bio-fuel sector. With India aiming to achieve 20% ethanol blending by 2025-26, TruAlt Bioenergy stands at the right place at the right time.

TruAlt Bioenergy IPO GMP Today

The Grey Market Premium (GMP) is one of the most tracked indicators ahead of an IPO listing. GMP shows the unofficial premium at which shares are being traded in the grey market before listing.

• As of today (22 September 2025), market trackers indicate that TruAlt Bioenergy IPO GMP is hovering around ₹20–₹30 per share.

• This suggests a modest listing gain of about 4–6% over the upper price band (₹496).

• However, GMP can fluctuate sharply depending on subscription numbers, market sentiment, and institutional demand.

Investors should note that while GMP gives a signal of demand, it is not the only factor to decide whether to apply or avoid. Strong fundamentals and long-term growth outlook often matter more than short-term premiums.

TruAlt Bioenergy IPO Subscription Status Live

Subscription status reveals how much demand the IPO is attracting across categories:

1. QIB (Qualified Institutional Buyers) – Expected to show strong interest due to government policies on ethanol and bio-fuels.

2. NII (Non-Institutional Investors) – High net-worth investors may wait for GMP trends before large bids.

3. Retail Investors – Early trends suggest decent participation because of affordable lot size.

On Day 1 (25 September 2025): Subscription numbers are expected to be moderate, with retail demand kicking in first.
By Day 2 and 3, QIB and institutional demand will likely push total subscription higher.

(We will update live subscription data as bidding progresses).

Company Financial Performance

TruAlt Bioenergy has delivered impressive growth in recent years.

• Revenue: ₹1,907 crore in FY25 vs ₹1,223 crore in FY24.

• Profit After Tax: ₹146 crore in FY25 vs ₹32 crore in FY24.

• EBITDA Margin: Improved significantly, showcasing operational efficiency.

The company’s plan to implement multi-feedstock operations is also a major plus. This will allow them to use multiple raw materials (sugarcane, grains, molasses) to produce ethanol, making operations more flexible and cost-efficient.

Strengths of TruAlt Bioenergy IPO

1. Strong Government Support – Bio-fuel sector is directly backed by government incentives and policies.

2. Fast Growth – Revenue and profit growth have been very strong in FY25.

3. Sustainability Play – Rising global ESG focus makes renewable energy companies attractive.

4. Expansion Plans – Multi-feed flexibility will reduce risks linked to raw material prices.

Risks to Consider Before Applying

1. Policy Dependence – Heavy reliance on government blending targets and subsidies.

2. Volatile Raw Material Costs – Grains and sugarcane prices can impact margins.

3. Sector Competition – Several companies are entering the ethanol and bio-fuel market.

4. GMP Uncertainty – Current GMP is positive but not very strong, making short-term gains unpredictable.

Should You Apply or Avoid TruAlt Bioenergy IPO?

• Apply if you are a long-term investor: TruAlt Bioenergy IPO offers strong fundamentals, government support, and a clear role in India’s renewable energy future. Holding for 2–3 years could deliver excellent returns.

• Avoid if you are only looking for listing gains: With GMP in the ₹20–₹30 range, listing gains may be limited. If you are purely chasing short-term profit, this IPO carries risk.

• Balanced Approach: Conservative investors can wait until Day 2–3 to see subscription data before making a final decision.

Expert Review on TruAlt Bioenergy IPO

Market experts believe TruAlt Bioenergy has a promising future in ethanol and bio-fuel, but short-term listing gains may be modest compared to other high-demand IPOs. Analysts suggest retail investors should treat this as a long-term wealth-creation opportunity rather than a quick flip.

FAQs on TruAlt Bioenergy IPO 2025

Q1. What is the GMP of TruAlt Bioenergy IPO today?
A1. As of today, GMP is around ₹20–₹30 per share, indicating modest listing gains.

Q2. When will TruAlt Bioenergy IPO open and close?
A2. The IPO will open on 25 September 2025 and close on 29 September 2025.

Q3. What is the price band of TruAlt Bioenergy IPO?
A3. The price band is fixed at ₹472 – ₹496 per share.

Q4. What is the lot size and minimum investment for retail investors?
A4. Lot size is 30 shares, requiring a minimum investment of approx. ₹14,160.

Q5. On which exchanges will TruAlt Bioenergy IPO list?
A5. The shares will be listed on both NSE and BSE.

Q6. What is the expected listing date?
A6. The expected listing date is 3 October 2025.

Q7. Should I apply to TruAlt Bioenergy IPO for listing gains?
A7. Short-term gains may be limited as GMP is modest. Long-term investors may find better value.

Q8. What will the IPO proceeds be used for?
A8. Proceeds will be used for plant expansion, multi-feedstock operations, working capital, and general purposes.

Q9. Is TruAlt Bioenergy IPO good for long-term investment?
A9. Yes, considering strong financial growth and government support, it has potential for long-term investors.

Q10. Who are the lead managers of this IPO?
A10. Major investment banks are managing the issue, ensuring strong institutional participation.